Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...

The treatment involves inserting a tiny implant thinner than human hair under the retina. Patients then have to wear glasses ...

Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...

Find out how asparagus and vanilla orchids demonstrate the importance of cell walls in plant survival and adaptability.

CINCINNATI—Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver ...